GAMMA Investing’s LENZ Therapeutics LENZ Stock Holding History

GAMMA Investing’s Portfolio LENZ Stock Details LENZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$3.42K	Buy	892 +406	+84%	+$2.02K	﹤0.01%	3794
2026 Q2	$2.76K	Buy	486 +58	+14%	+$467	﹤0.01%	3668
2026 Q1	$3.92K	Buy	428 +174	+69%	+$2.44K	﹤0.01%	3454
2025 Q4	$4.06K	Sell	254 -58	-19%	-$1.69K	﹤0.01%	3367
2025 Q3	$14.5K	Buy	312 +25	+9%	+$919	﹤0.01%	2688
2025 Q2	$8.41K	Buy	287 +60	+26%	+$1.63K	﹤0.01%	2899
2025 Q1	$5.84K	Buy	227 +118	+108%	+$2.91K	﹤0.01%	3023
2024 Q4	$3.15K	Buy	109 +27	+33%	+$823	﹤0.01%	3073
2024 Q3	$1.95K	Buy	82 +51	+165%	+$1.13K	﹤0.01%	3077
2024 Q2	$536	Buy	+31	New	+$542	﹤0.01%	3199

Other funds holding LENZ

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

Essential Partners Rancho Santa Fe, California $219M AUM 37.92% 1-Year Est. Return

TWD

True Wealth Design Akron, Ohio $426M AUM 16.34% 1-Year Est. Return

GAMMA Investing's LENZ Position: Q3 2026 in Review

GAMMA Investing increased its LENZ Therapeutics (LENZ) stake by 84% in Q3 2026, buying an estimated $2.02K and bringing the position to 892 shares worth $3.42K. The position accounts for ﹤0.01% of the portfolio, ranked #3794.

GAMMA Investing first reported a position in LENZ in Q2 2024 and has held it in 10 quarters since. The position peaked at $14.5K in Q3 2025. 4 funds tracked by Wall St. Rank hold LENZ as of Q3 2026.

GAMMA Investing held 892 shares of LENZ Therapeutics worth $3.42K as of Q3 2026.
GAMMA Investing bought 406 LENZ Therapeutics shares in Q3 2026, an estimated $2.02K.
LENZ Therapeutics made up ﹤0.01% of GAMMA Investing's portfolio in Q3 2026, its #3794 holding.
GAMMA Investing first reported a position in LENZ Therapeutics in Q2 2024 and has held it in 10 quarters since.
GAMMA Investing's LENZ Therapeutics position peaked at $14.5K in Q3 2025.
4 funds tracked by Wall St. Rank held LENZ Therapeutics as of Q3 2026.

Based on GAMMA Investing's 13F filing for Q3 2026, filed 8 Oct 2026.